AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Acurx Pharmaceuticals, Inc. Director's Dealing 2021

Jun 25, 2021

35349_dirs_2021-06-24_2ceec00c-4b7f-48cd-a1b0-e19d152516b5.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Acurx Pharmaceuticals, Inc. (ACXP)
CIK: 0001736243
Period of Report: 2021-06-24

Reporting Person: Scodari Joseph C (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3077	Direct

Footnotes

F1: Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.